The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver
fibrosis is predominantly based on their immunosuppressive properties, and their ability to …

Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …

For the past decades, heart diseases remain the leading cause of death worldwide. In the
adult mammalian heart, damaged cardiomyocytes will be replaced by non-contractile fibrotic …

Chronic liver diseases have become a significant health issue worldwide and urgently
require the development of novel therapeutic approaches, in addition to liver transplantation …

Human amniotic membrane-derived mesenchymal stromal cells (hAMSCs) are easily
obtained in large quantities and free from ethical concerns. Promising therapeutic results for …

Among the many cell types useful in developing therapeutic treatments, human amniotic
cells from placenta have been proposed as valid candidates. Both human amniotic epithelial …

Amniotic mesenchymal stromal cells (hAMSCs) have unique immunomodulatory properties
demonstrated in vitro and in vivo in various diseases in which the dysregulated immune …

Human amniotic membrane (hAM) is the innermost layer of fetal membranes, which
surrounds the developing fetus and forms the amniotic cavity. hAM and hAM-derived cells …

The liver is a vital organ responsible for metabolic and digestive functions, protein synthesis,
detoxification, and numerous other necessary functions. Various acute, chronic, and …

Mesenchymal stromal cells (MSC) from the amniotic membrane of human term placenta
(hAMSC), and the conditioned medium generated from their culture (CM-hAMSC) offer …